Ophthalmologist Dr. Arnold Prywes has fulfilled a mission years in the making — helping a patient with a challenging case of glaucoma by implanting a sight-saving device that he invented in 1991.

Betty Fecteau, left, 85, of West Seneca, had a tiny stent surgically placed into her right eye in May by Dr. Paul C. Holmwood, right, an ophthalmologist with Eye Care & Vision Associates, which has ...

Glaukos secured a new FDA clearance for its miniaturized stent system designed for glaucoma to help drain the inner eye of built-up fluids and normalize intraocular pressure. The company had received ...

Novartis’ Alcon eye care division has withdrawn all versions of its CyPass micro-stent from the global market following new data from a long-term safety study. Used to relieve pressure under the eye ...

Please provide your email address to receive an email when new articles are posted on . Non-stent MIGS devices demonstrated better success rates from 6 to 24 months after surgery. However, eyes in the ...

NEW YORK (CBSNewYork) --A tiny new device could help prevent a leading cause of blindness. The glaucoma implant is the size of a human hair, and was just approved by the Food and Drug Administration.

The London Ophthalmology Centre (LondonOC) has developed a new, non-invasive technique for the application of Xen stent into the eye to treat acute glaucoma. The micro device and new technique was ...

Blake Williamson, MD, performed the first Xen Gel Stent procedure form Allergan Surgical in Louisiana at the Williamson Eye Center in Baton Rouge, according to a Weekly Citizen report. 1. The Xen Gel ...

Ivantis Inc. in Irvine closed on a $25 million Series C funding round for development and eventual marketing of a stent intended for use in glaucoma surgery. New investor RA Capital Management LLC in ...

ZURICH, Aug 29 (Reuters) - Novartis eye care unit Alcon is voluntarily withdrawing its CyPass Micro-Stent after follow-up clinical data showed patients using the product experienced statistically ...